Parkman Healthcare Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-76,079
| Closed | -$6.29M | – | 98 |
|
|
2024
Q2 | $6.29M | Sell |
76,079
-14,883
| -16% | -$1.23M | 0.84% | 42 |
|
|
2024
Q1 | $7.76M | Buy |
90,962
+21,022
| +30% | +$1.79M | 0.95% | 39 |
|
|
2023
Q4 | $5.98M | Sell |
69,940
-19,022
| -21% | -$1.63M | 0.84% | 37 |
|
|
2023
Q3 | $7.97M | Sell |
88,962
-26,099
| -23% | -$2.34M | 1.46% | 20 |
|
|
2023
Q2 | $9.8M | Sell |
115,061
-25,679
| -18% | -$2.19M | 1.7% | 20 |
|
|
2023
Q1 | $11.6M | Buy |
140,740
+8,362
| +6% | +$692K | 2.53% | 7 |
|
|
2022
Q4 | $10.4M | Buy |
132,378
+16,581
| +14% | +$1.3M | 2.77% | 8 |
|
|
2022
Q3 | $8.57M | Buy |
115,797
+90,797
| +363% | +$6.72M | 2.44% | 10 |
|
|
2022
Q2 | $1.63M | Buy |
+25,000
| New | +$1.63M | 0.6% | 46 |
|
|
2021
Q2 | – | Sell |
-17,500
| Closed | -$1.94M | – | 88 |
|
|
2021
Q1 | $1.94M | Buy |
+17,500
| New | +$1.94M | 0.45% | 56 |
|
|
2020
Q3 | – | Sell |
-30,147
| Closed | -$2.7M | – | 88 |
|
|
2020
Q2 | $2.7M | Buy |
30,147
+15,000
| +99% | +$1.34M | 0.76% | 45 |
|
|
2020
Q1 | $1.51M | Sell |
15,147
-45,103
| -75% | -$4.5M | 0.7% | 46 |
|
|
2019
Q4 | $6.92M | Buy |
+60,250
| New | +$6.92M | 2% | 20 |
|